{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:35:20Z","timestamp":1790339720975,"version":"4.1.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"vor","delay-in-days":88,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The purpose of this study was to evaluate the efficacy and toxicities of carbon-ion radiotherapy (C-ion RT) for locally advanced cervical cancer with bladder invasion by a subset analysis of pooled data from eight prospective clinical trials at the National Institute of Radiological Sciences. Between June 1995 and January 2014, 29 patients with locally advanced cervical cancer with bladder invasion were identified. The median age was 56 years old (range 31\u201379 years old). The median tumor size at diagnosis on magnetic resonance imaging was 6.7 cm (range 3.5\u201311.0 cm). Histologically, 20 patients had squamous cell carcinoma and 9 had adenocarcinoma. C-ion RT was performed as a dose-escalation study in the initial trials. All patients received prophylactic whole-pelvic or extended-field irradiation and local boost. The total dose to the cervical tumor was 52.8\u201374.4 Gy (relative biological effectiveness) in 20 or 24 fractions. Weekly cisplatin (40 mg\/m2\/week, five cycles) was concurrently given to four patients. The median follow-up of all patients was 28.6 months (range 8.8\u2013238.6 months). Grade 2 or higher late complications in the bladder were observed in eight patients, with seven developing vesicovaginal fistula. Six patients had Grade 2 or higher complications in the rectosigmoid colon. The 3-year overall survival rate was 47%, the 3-year local control rate was 66%, and the 3-year disease-free survival rate was 28%. In this study, C-ion RT showed favorable local control with reasonable toxicities, but the results were still unsatisfactory. We have the expectation of improvement of therapeutic effects by using C-ion RT with concurrent chemotherapy.<\/jats:p>","DOI":"10.1093\/jrr\/rrw070","type":"journal-article","created":{"date-parts":[[2016,7,15]],"date-time":"2016-07-15T22:59:13Z","timestamp":1468623553000},"page":"684-690","source":"Crossref","is-referenced-by-count":17,"title":["Carbon-ion radiotherapy for locally advanced cervical cancer with bladder invasion"],"prefix":"10.1093","volume":"57","author":[{"given":"Shintaro","family":"Shiba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Wakatsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Okonogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Karasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kiyohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohiko","family":"Tsujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Kamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makio","family":"Shozu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Working Group of the Gynecological Tumor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,12,2]]},"reference":[{"key":"2020010903081890200_rrw070C1","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ijc.11719","article-title":"Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost","volume":"109","author":"Yang","year":"2004","journal-title":"Int J Cancer"},{"issue":"Suppl 1","key":"2020010903081890200_rrw070C2","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0020-7292(06)60030-1","article-title":"Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Quinn","year":"2006","journal-title":"Int J Gynaecology and obstetrics: the official organ of the International Federation of Gynaecol Obstet"},{"key":"2020010903081890200_rrw070C3","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0020-7292(06)60030-1","article-title":"Carcinoma of the Cervix Uteri","volume":"95","author":"Quinn","year":"2006","journal-title":"Int J Gynecol Obstet"},{"key":"2020010903081890200_rrw070C4","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ygyno.2011.02.024","article-title":"Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study","volume":"121","author":"Rose","year":"2011","journal-title":"Gynecol Oncol"},{"key":"2020010903081890200_rrw070C5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12885-016-2268-3","article-title":"The prognostic value of rectal invasion for stage IVA uterine cervical cancer treated with radiation therapy","volume":"16","author":"Wakatsuki","year":"2016","journal-title":"BMC Cancer"},{"key":"2020010903081890200_rrw070C6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/cncr.20734","article-title":"Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix","volume":"103","author":"Nakano","year":"2005","journal-title":"Cancer"},{"key":"2020010903081890200_rrw070C7","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/jjco\/hys104","article-title":"A review of update clinical results of carbon ion radiotherapy","volume":"42","author":"Tsujii","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"2020010903081890200_rrw070C8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/095530098141799","article-title":"Mouse skin reactions following fractionated irradiation with carbon ions","volume":"74","author":"Ando","year":"1998","journal-title":"Int J Radiat Biol"},{"key":"2020010903081890200_rrw070C9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0360-3016(98)00544-6","article-title":"Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy","volume":"44","author":"Kanai","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020010903081890200_rrw070C10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2307\/3579446","article-title":"Irradiation of mixed beam and design of spread-out Bragg peak for heavy-ion radiotherapy","volume":"147","author":"Kanai","year":"1997","journal-title":"Radiat Res"},{"key":"2020010903081890200_rrw070C11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/jrr\/rrt120","article-title":"Clinical trial of carbon ion radiotherapy for gynecological melanoma","volume":"55","author":"Karasawa","year":"2014","journal-title":"J Radiat Res"},{"key":"2020010903081890200_rrw070C12","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1038\/bjc.2014.191","article-title":"Phase I\/II trial of definitive carbon ion radiotherapy for prostate cancer: evaluation of shortening of treatment period to 3 weeks","volume":"110","author":"Nomiya","year":"2014","journal-title":"Br J Cancer"},{"key":"2020010903081890200_rrw070C13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/cncr.27723","article-title":"Phase 1 trial of preoperative, short-course carbon-ion radiotherapy for patients with resectable pancreatic cancer","volume":"119","author":"Shinoto","year":"2013","journal-title":"Cancer"},{"key":"2020010903081890200_rrw070C14","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/cncr.29195","article-title":"A prospective nonrandomized phase I\/II study of carbon ion radiotherapy in a favorable subset of locally advanced non\u2013small cell lung cancer (NSCLC)","volume":"121","author":"Takahashi","year":"2015","journal-title":"Cancer"},{"key":"2020010903081890200_rrw070C15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ijrobp.2005.12.050","article-title":"Dose escalation study of carbon ion radiotherapy for locally advanced carcinoma of the uterine cervix","volume":"65","author":"Kato","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020010903081890200_rrw070C16","first-page":"362","article-title":"The phase I\/II clinical study of carbon ion therapy for cancer of the uterine cervix","volume":"5","author":"Nakano","year":"1999","journal-title":"Cancer J Sci Am"},{"key":"2020010903081890200_rrw070C17","doi-asserted-by":"crossref","first-page":"e0127587","DOI":"10.1371\/journal.pone.0127587","article-title":"Clinical trial of prophylactic extended-field carbon-ion radiotherapy for locally advanced uterine cervical cancer (Protocol 0508)","volume":"10","author":"Wakatsuki","year":"2015","journal-title":"PLoS One"},{"key":"2020010903081890200_rrw070C18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ygyno.2013.10.021","article-title":"Dose-escalation study of carbon ion radiotherapy for locally advanced squamous cell carcinoma of the uterine cervix (9902)","volume":"132","author":"Wakatsuki","year":"2014","journal-title":"Gynecol Oncol"},{"key":"2020010903081890200_rrw070C19","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/cncr.28621","article-title":"Clinical outcomes of carbon ion radiotherapy for locally advanced adenocarcinoma of the uterine cervix in phase 1\/2 clinical trial (protocol 9704)","volume":"120","author":"Wakatsuki","year":"2014","journal-title":"Cancer"},{"key":"2020010903081890200_rrw070C20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/jrr\/rru117","article-title":"Difference in distant failure site between locally advanced squamous cell carcinoma and adenocarcinoma of the uterine cervix after C-ion RT","volume":"56","author":"Wakatsuki","year":"2015","journal-title":"J Radiat Res"},{"key":"2020010903081890200_rrw070C21","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1088\/0031-9155\/60\/8\/3271","article-title":"Reformulation of a clinical-dose system for carbon-ion radiotherapy treatment planning at the National Institute of Radiological Sciences, Japan","volume":"60","author":"Inaniwa","year":"2015","journal-title":"Phys Med Biol"},{"key":"2020010903081890200_rrw070C22","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020010903081890200_rrw070C23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/IGC.0b013e3181d224c8","article-title":"Can we predict vesicovaginal or rectovaginal fistula formation in patients with stage IVA cervical cancer","volume":"20","author":"Biewenga","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"2020010903081890200_rrw070C24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0090-8258(89)90633-1","article-title":"Radiation treatment of FIGO stage IVA carcinoma of the cervix","volume":"32","author":"Kramer","year":"1989","journal-title":"Gynecol Oncol"},{"key":"2020010903081890200_rrw070C25","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ygyno.2007.04.030","article-title":"Vesicovaginal fistula formation in patients with Stage IVA cervical carcinoma","volume":"106","author":"Moore","year":"2007","journal-title":"Gynecol Oncol"},{"key":"2020010903081890200_rrw070C26","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/1097-0142(19830415)51:8<1393::AID-CNCR2820510812>3.0.CO;2-M","article-title":"Radiation therapy alone in the treatment of carcinoma of uterine cervix. I. Analysis of tumor recurrence","volume":"51","author":"Perez","year":"1983","journal-title":"Cancer"},{"key":"2020010903081890200_rrw070C27","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","article-title":"The linear\u2013quadratic formula and progress in fractionated radiotherapy","volume":"62","author":"Fowler","year":"1989","journal-title":"Br J Radiol"},{"key":"2020010903081890200_rrw070C28","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/IGC.0b013e3181e6f321","article-title":"Patient outcome study of concurrent chemoradiation, external beam radiotherapy, and high-dose rate brachytherapy in locally advanced carcinoma of the cervix","volume":"20","author":"Forrest","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"2020010903081890200_rrw070C29","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.ijrobp.2011.04.047","article-title":"Outcomes of chemoradiotherapy in cervical cancer\u2014the Western Australian experience","volume":"82","author":"Lim","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020010903081890200_rrw070C30","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0360-3016(95)00010-V","article-title":"Radiation therapy alone for adenocarcinoma of the uterine cervix","volume":"32","author":"Nakano","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020010903081890200_rrw070C31","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/1097-0142(19900601)65:11<2507::AID-CNCR2820651120>3.0.CO;2-9","article-title":"Adenocarcinoma of the uterine cervix. Prognosis and patterns of failure in 367 cases","volume":"65","author":"Eifel","year":"1990","journal-title":"Cancer"},{"key":"2020010903081890200_rrw070C32","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0360-3016(03)00007-5","article-title":"Comparison of prognostic value of MRI and FIGO stage among patients with cervical carcinoma treated with radiotherapy","volume":"56","author":"Kodaira","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020010903081890200_rrw070C33","volume-title":"Radiobiology for the Radiologist.","author":"Hall","year":"2012","edition":"7th edn."},{"key":"2020010903081890200_rrw070C34","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2307\/3576354","article-title":"Reduced oxygen enhancement ratio at low doses of ionizing radiation","volume":"100","author":"Palcic","year":"1984","journal-title":"Radiat Res"},{"key":"2020010903081890200_rrw070C35","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1525-1438.2006.00341.x","article-title":"Oxygenated and reoxygenated tumors show better local control in radiation therapy for cervical cancer","volume":"16","author":"Suzuki","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"2020010903081890200_rrw070C36","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/j.1349-7006.2003.tb01395.x","article-title":"Tumor hypoxia: a target for selective cancer therapy","volume":"94","author":"Kizaka-Kondoh","year":"2003","journal-title":"Cancer Sci"},{"key":"2020010903081890200_rrw070C37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mrgentox.2013.05.008","article-title":"Evaluation of SCCVII tumor cell survival in clamped and non-clamped solid tumors exposed to carbon-ion beams in comparison to X-rays","volume":"756","author":"Hirayama","year":"2013","journal-title":"Mutat Res"},{"key":"2020010903081890200_rrw070C38","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1158\/1078-0432.CCR-05-1907","article-title":"Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia","volume":"12","author":"Nakano","year":"2006","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Radiation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jrr\/article\/57\/6\/684\/2605897","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jrr\/article\/57\/6\/684\/2605897","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T03:13:18Z","timestamp":1578539598000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jrr\/article\/57\/6\/684\/2605897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,12,2]]},"published-print":{"date-parts":[[2016,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jrr\/rrw070","relation":{},"ISSN":["0449-3060","1349-9157"],"issn-type":[{"value":"0449-3060","type":"print"},{"value":"1349-9157","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,9]]},"published":{"date-parts":[[2016,9]]}}}